COMPARATIVE CHANGE IN QUALITY OF LIFE MEASURES IN PRECLINICAL AND ESTABLISHED PSORIATIC ARTHRITIS PATIENTSUNDER SECUKINUMAB TREATMENT. DATA DERIVED FROM THE PROSPECTIVE OPEN LABEL PSARTROS STUDY

Kampylafka E, Englbrecht M, Tascilar K, Lerchen V, Linz C, Kleyer A, Simon D, Rech J, Schett G, Hueber A (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 1845-1845

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

Event location: Madrid ES

DOI: 10.1136/annrheumdis-2019-eular.2628

Authors with CRIS profile

Matthias Englbrecht Lehrstuhl für Innere Medizin III Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology David Simon Department of Medicine 3 – Rheumatology and Immunology Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III Axel Hueber

Involved external institutions

Sozialstiftung Bamberg DE Germany (DE)

How to cite

APA:

Kampylafka, E., Englbrecht, M., Tascilar, K., Lerchen, V., Linz, C., Kleyer, A.,... Hueber, A. (2019). COMPARATIVE CHANGE IN QUALITY OF LIFE MEASURES IN PRECLINICAL AND ESTABLISHED PSORIATIC ARTHRITIS PATIENTSUNDER SECUKINUMAB TREATMENT. DATA DERIVED FROM THE PROSPECTIVE OPEN LABEL PSARTROS STUDY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1845-1845). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.

MLA:

Kampylafka, Eleni, et al. "COMPARATIVE CHANGE IN QUALITY OF LIFE MEASURES IN PRECLINICAL AND ESTABLISHED PSORIATIC ARTHRITIS PATIENTSUNDER SECUKINUMAB TREATMENT. DATA DERIVED FROM THE PROSPECTIVE OPEN LABEL PSARTROS STUDY." Proceedings of the Annual European Congress of Rheumatology (EULAR), Madrid LONDON: BMJ PUBLISHING GROUP, 2019. 1845-1845.

BibTeX: Download